Cargando…
Stratifying primary Sjögren’s syndrome: killers in the balance?
The article by Seror et al. in Arthritis Research & Therapy reports data from the 15 French patients in the open-label BELISS (Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome, NCT01160666) study of belimumab in primary Sjögren’s syndrome. The study identifies th...
Autores principales: | Bowman, Simon J., Fisher, Benjamin A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671212/ https://www.ncbi.nlm.nih.gov/pubmed/26639390 http://dx.doi.org/10.1186/s13075-015-0878-9 |
Ejemplares similares
-
A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sjögren's Syndrome
por: Stack, Rebecca J., et al.
Publicado: (2017) -
B-cell activity markers are associated with different disease activity domains in primary Sjögren’s syndrome
por: James, Katherine, et al.
Publicado: (2018) -
Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome
por: Seror, Raphaele, et al.
Publicado: (2022) -
IL-21 and Sjögren's syndrome
por: Scofield, R Hal
Publicado: (2011) -
Sjogren’s Syndrome: Recent Updates
por: Skarlis, Charalampos, et al.
Publicado: (2022)